2015
DOI: 10.1021/acsami.5b00484
|View full text |Cite
|
Sign up to set email alerts
|

New Frontiers for Encapsulation in the Chemical Industry

Abstract: Encapsulation of actives comprises an area of exploration undergoing rapid growth in both academic and industrial research settings. Encapsulation processes are employed as a part of product synthesis processes for improved efficiency, enhanced stability, active ingredient compatibility, increased safety, targeted delivery, and novel performance of the end product. Such technical benefits enable producers to offer products with increased formulation complexity, access new markets, differentiate products, and i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
51
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(53 citation statements)
references
References 120 publications
0
51
0
2
Order By: Relevance
“…2,3 Increasing interest is focused on rational design of non-viral vectors with improved safety and ease to synthesize. [4][5][6] Liposomal drug-delivery systems have been demonstrated as one of the most promising non-viral vectors with great clinical potential since the first nanomedicine (Doxil Âź ) approved by FDA in 1995 is based on the use of liposomes. 7 However, conventional liposomes usually exhibit low colloidal stability, difficulties in achieving controlled drug delivery/release, fast elimination, and a lack of targeting effect, which have greatly limited their clinical applications.…”
Section: Introductionmentioning
confidence: 99%
“…2,3 Increasing interest is focused on rational design of non-viral vectors with improved safety and ease to synthesize. [4][5][6] Liposomal drug-delivery systems have been demonstrated as one of the most promising non-viral vectors with great clinical potential since the first nanomedicine (Doxil Âź ) approved by FDA in 1995 is based on the use of liposomes. 7 However, conventional liposomes usually exhibit low colloidal stability, difficulties in achieving controlled drug delivery/release, fast elimination, and a lack of targeting effect, which have greatly limited their clinical applications.…”
Section: Introductionmentioning
confidence: 99%
“…PUF microcapsules form quite effective barriers for liquids and therefore are widely utilized in academia and industry. 30 Optical microscopy (Figure 2a and 2b) and scanning electron microscopy ( Figure 2c and 2d) images reveal that the particles produced are spherical, closed, and that they have a relatively In order to confirm and quantify the encapsulation of the donor and acceptor molecules, respectively, into the microcapsules prepared, they were mechanically crushed and the payload was extracted with an organic solvent. Gratifyingly, FTIR spectra (Figure 3a and 3b), 1 H NMR spectra and mass spectra (Supporting Information, Figures S1-S6) confirm that the extracted payload consists exclusively of HMB and CA, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…[1][2][3][4][5][6][7][8][9][10] A variety of chemical architectures, such as carbon nanotubes, [11] microporous inorganic materials, [12,13] polymers, [14] and supramolecular macrocyclic hosts, [15][16][17][18] have been employed as carriers for small molecules. [1][2][3][4][5][6][7][8][9][10] A variety of chemical architectures, such as carbon nanotubes, [11] microporous inorganic materials, [12,13] polymers, [14] and supramolecular macrocyclic hosts, [15][16][17][18] have been employed as carriers for small molecules.…”
Section: Introductionmentioning
confidence: 99%